Chennai Meenakshi Multispeciality Hospital Ltd
BSE:523489
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Chennai Meenakshi Multispeciality Hospital Ltd
Income from Continuing Operations
Chennai Meenakshi Multispeciality Hospital Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Chennai Meenakshi Multispeciality Hospital Ltd
BSE:523489
|
Income from Continuing Operations
-₹8.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
-8%
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Income from Continuing Operations
₹14.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
28%
|
CAGR 10-Years
16%
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Income from Continuing Operations
₹9.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
22%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Income from Continuing Operations
₹14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Income from Continuing Operations
₹7.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Income from Continuing Operations
₹4.8B
|
CAGR 3-Years
35%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
Chennai Meenakshi Multispeciality Hospital Ltd
Glance View
Chennai Meenakshi Multispeciality Hospital Ltd. operates as a hospital, which provides healthcare services. The company is headquartered in Chennai, Tamil Nadu. The firm operates an approximately 100-bedded hospital located at Mylapore. The firm's services include cardiology, cosmetic and plastic surgery, diabetology, endocrinology, dermatology, dentistry, surgical gastroenterology, general surgery, gynecology, vascular surgery, minimal access general and metabolic tumors surgery, neurology, neuro surgery, orthopedics, pediatrics, pediatric gastroenterology, ophthalmology and pulmonology. The company also offers a range of programs, such as Basic Health Check Up, which include hematology and bio-chemistry; Master Health Check Up, which include hematology, bio-chemistry, lipid profile, general tests and liver function test (LFT), and Executive Health Check Up, which include hematology, bio-chemistry, renal profile, lipid profile, LFT and general tests.
See Also
What is Chennai Meenakshi Multispeciality Hospital Ltd's Income from Continuing Operations?
Income from Continuing Operations
-8.2m
INR
Based on the financial report for Dec 31, 2025, Chennai Meenakshi Multispeciality Hospital Ltd's Income from Continuing Operations amounts to -8.2m INR.
What is Chennai Meenakshi Multispeciality Hospital Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-8%
Over the last year, the Income from Continuing Operations growth was 62%.